Hematology NewsMinimal residual disease measures not yet impactful for AML patientsOctober 12, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesFDA grants drug fast track designation for rel/ref AMLOctober 12, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesAML trial placed on full clinical holdOctober 11, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesFDA grants drug orphan designation for AMLOctober 10, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesNewer blood cancer drugs may not improve OS, QOLOctober 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Hematology TimesMutations impact outcomes in AML, MDSSeptember 27, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesHow APL cells evade the immune systemSeptember 24, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsFlotetuzumab for AML passes phase 1 testSeptember 21, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesMidostaurin approved to treat AML, SM in EuropeSeptember 21, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesFDA grants RMAT designation to HSCT adjunctSeptember 21, 2017AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationAMLALLMyelodysplastic Syndrome
Hematology TimesTeam creates guidelines on CAR T-cell-related toxicitySeptember 20, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesAntibody shows early promise in AML/MDS trialSeptember 20, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology NewsAML risk is doubled in low-risk thyroid cancer patients unnecessarily given radioactive iodine therapySeptember 18, 2017AMLHead & Neck/Thyroid Cancers
